FDA approves Pfizer canine obesity drug

Share this article:
Slentrol should be available "in the spring," according to Pfizer Animal Health. The once-daily drug should cost between $1 and $2 a dose, a company spokeswoman told the Associated Press. Stephen Sundlof, director of Center of Veterinary Medicine at the FDA, called Slentrol “a welcome addition to animal therapies because dog obesity appears to be increasing.” Veterinarians generally define a dog that weighs 20 percent more than its ideal weight as obese. Surveys have found that approximately 5% of dogs in the US are obese and another 20-30% are overweight.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.